CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
FEV1other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02660853
NCT02660853N/ACompleted
CompareCT.gov

Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers

Imperial College London·interventional·Posted Jan 21, 2016·Updated Dec 3, 2019

In Brief

A clinical study evaluating FEV1 for Asthma. Completed, enrolled 25 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate exacerbations in severe asthma with regard to symptoms, lung function, aetiology and biomarkers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited Kingdom
CollaboratorsRoyal Brompton & Harefield NHS Foundation Trust

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 21, 2016
Enrollment StartJun 1, 2015
Primary CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.4 years ago

Interventions

FEV1other

Participants have FEV1 test